iOnctura
ID: 7645295iOnctura is a Geneve-based biotechnology company focused on immuno-oncology that develops selective cancer therapies.
4
Funding Rounds
$124.4m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding
Funding series
Funding Series Analysis
The company iOnctura has raised a total of $124.4m in funding over 4 rounds.
Key Insights:
- iOnctura June 2024 Series B Funding Round: $86m
- iOnctura December 2022 Series B Funding Round: $16m
- iOnctura Series A round (extension), July 2020: $5.8m
- iOnctura Series A round, January 2020: $16.6m
Industries
iOnctura is active in the following industries: